EFM
EVMN

EQT Fund Management’s Evommune Inc EVMN Stock Holding History

EQT Fund Management’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.3M Buy
5,288,313
+358,680
+7% +$8.33M 8.15% 4
2026
Q1 		$113M Hold
4,929,633
– – 11.1% 3
2025
Q4 		$84.4M Buy
+4,929,633
New +$92.6M 7.59% 4

Other funds holding EVMN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

EQT Fund Management's EVMN Position: Q2 2026 in Review

EQT Fund Management increased its Evommune Inc (EVMN) stake by 7.3% in Q2 2026, buying an estimated $8.33M and bringing the position to 5,288,313 shares worth $70.3M. The position accounts for 8.15% of the portfolio, ranked #4.

EQT Fund Management first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. The position peaked at $113M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • EQT Fund Management held 5,288,313 shares of Evommune Inc worth $70.3M as of Q2 2026.
  • EQT Fund Management bought 358,680 Evommune Inc shares in Q2 2026, an estimated $8.33M.
  • Evommune Inc made up 8.15% of EQT Fund Management's portfolio in Q2 2026, its #4 holding.
  • EQT Fund Management first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • EQT Fund Management's Evommune Inc position peaked at $113M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on EQT Fund Management's 13F filing for Q2 2026, filed 13 Aug 2026.